Egési sebfertözésekböl izolált aerob baktériumok megoszlása és antibiotikum rezisztenciája.

Translated title of the contribution: Distribution and antibiotic resistance of aerobic bacteria isolated from infected wounds caused by burns

J. Szabó, E. Belicza, I. Rédal, F. Rozgonyi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Distribution according to species and genus and resistance to antibacterial agents was studied with 420 bacterial isolates cultured from the wound excretion of 282 burned-infected patients. Of the isolates 68.2% was Gram-positive and 31.8% Gram-negative. This latter high rate may be due to fecal infection as 21% of the burned patients was between the age of 0-4 years. Of the total isolates 38.3% was Staphylococcus aureus, 16.7% coagulase-negative staphylococcus, 10.7% Pseudomonas strain, 6.9% Escherichia coli and 4.8% Klebsiella. Vancomycin resistant Staphylococcus strain was not found. On the other hand 30-35% of the strains was cross-resistant to methicillin- oxacillin-cefuroxim-clindamycin though these agents are the most potent following the vancomycine. Ceftazidime is the most effective agent for Pseudomonas strains being followed by amikacin, carbenicillin, tobramycin and ceftriaxon. Other Gram-negative bacteria showed strongest sensitivity to ceftazidime and ceftriaxone and these are followed by amikacin.

Original languageHungarian
Pages (from-to)687-690, 693
JournalOrvosi Hetilap
Volume132
Issue number13
Publication statusPublished - Mar 31 1991

Fingerprint

Aerobic Bacteria
Ceftazidime
Amikacin
Ceftriaxone
Microbial Drug Resistance
Pseudomonas
Burns
Staphylococcus
Carbenicillin
Oxacillin
Tobramycin
Methicillin Resistance
Klebsiella
Clindamycin
Coagulase
Wounds and Injuries
Vancomycin
Gram-Negative Bacteria
Staphylococcus aureus
Escherichia coli

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Egési sebfertözésekböl izolált aerob baktériumok megoszlása és antibiotikum rezisztenciája. / Szabó, J.; Belicza, E.; Rédal, I.; Rozgonyi, F.

In: Orvosi Hetilap, Vol. 132, No. 13, 31.03.1991, p. 687-690, 693.

Research output: Contribution to journalArticle

@article{3378847c59dd4add97ed711f0fb5dee4,
title = "Eg{\'e}si sebfert{\"o}z{\'e}sekb{\"o}l izol{\'a}lt aerob bakt{\'e}riumok megoszl{\'a}sa {\'e}s antibiotikum rezisztenci{\'a}ja.",
abstract = "Distribution according to species and genus and resistance to antibacterial agents was studied with 420 bacterial isolates cultured from the wound excretion of 282 burned-infected patients. Of the isolates 68.2{\%} was Gram-positive and 31.8{\%} Gram-negative. This latter high rate may be due to fecal infection as 21{\%} of the burned patients was between the age of 0-4 years. Of the total isolates 38.3{\%} was Staphylococcus aureus, 16.7{\%} coagulase-negative staphylococcus, 10.7{\%} Pseudomonas strain, 6.9{\%} Escherichia coli and 4.8{\%} Klebsiella. Vancomycin resistant Staphylococcus strain was not found. On the other hand 30-35{\%} of the strains was cross-resistant to methicillin- oxacillin-cefuroxim-clindamycin though these agents are the most potent following the vancomycine. Ceftazidime is the most effective agent for Pseudomonas strains being followed by amikacin, carbenicillin, tobramycin and ceftriaxon. Other Gram-negative bacteria showed strongest sensitivity to ceftazidime and ceftriaxone and these are followed by amikacin.",
author = "J. Szab{\'o} and E. Belicza and I. R{\'e}dal and F. Rozgonyi",
year = "1991",
month = "3",
day = "31",
language = "Hungarian",
volume = "132",
pages = "687--690, 693",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "13",

}

TY - JOUR

T1 - Egési sebfertözésekböl izolált aerob baktériumok megoszlása és antibiotikum rezisztenciája.

AU - Szabó, J.

AU - Belicza, E.

AU - Rédal, I.

AU - Rozgonyi, F.

PY - 1991/3/31

Y1 - 1991/3/31

N2 - Distribution according to species and genus and resistance to antibacterial agents was studied with 420 bacterial isolates cultured from the wound excretion of 282 burned-infected patients. Of the isolates 68.2% was Gram-positive and 31.8% Gram-negative. This latter high rate may be due to fecal infection as 21% of the burned patients was between the age of 0-4 years. Of the total isolates 38.3% was Staphylococcus aureus, 16.7% coagulase-negative staphylococcus, 10.7% Pseudomonas strain, 6.9% Escherichia coli and 4.8% Klebsiella. Vancomycin resistant Staphylococcus strain was not found. On the other hand 30-35% of the strains was cross-resistant to methicillin- oxacillin-cefuroxim-clindamycin though these agents are the most potent following the vancomycine. Ceftazidime is the most effective agent for Pseudomonas strains being followed by amikacin, carbenicillin, tobramycin and ceftriaxon. Other Gram-negative bacteria showed strongest sensitivity to ceftazidime and ceftriaxone and these are followed by amikacin.

AB - Distribution according to species and genus and resistance to antibacterial agents was studied with 420 bacterial isolates cultured from the wound excretion of 282 burned-infected patients. Of the isolates 68.2% was Gram-positive and 31.8% Gram-negative. This latter high rate may be due to fecal infection as 21% of the burned patients was between the age of 0-4 years. Of the total isolates 38.3% was Staphylococcus aureus, 16.7% coagulase-negative staphylococcus, 10.7% Pseudomonas strain, 6.9% Escherichia coli and 4.8% Klebsiella. Vancomycin resistant Staphylococcus strain was not found. On the other hand 30-35% of the strains was cross-resistant to methicillin- oxacillin-cefuroxim-clindamycin though these agents are the most potent following the vancomycine. Ceftazidime is the most effective agent for Pseudomonas strains being followed by amikacin, carbenicillin, tobramycin and ceftriaxon. Other Gram-negative bacteria showed strongest sensitivity to ceftazidime and ceftriaxone and these are followed by amikacin.

UR - http://www.scopus.com/inward/record.url?scp=0026434518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026434518&partnerID=8YFLogxK

M3 - Article

C2 - 2014125

AN - SCOPUS:0026434518

VL - 132

SP - 687-690, 693

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 13

ER -